Company Filing History:
1 out of 15,475 
1 out of 3 
1 out of 3,539 
Years Active: 2011-2022
Title: Marcin Dyba: Innovator in Cancer Treatment
Introduction
Marcin Dyba is a notable inventor based in Frederick, MD (US), recognized for his contributions to cancer treatment through innovative research and development. He holds 2 patents that focus on K-Ras modulators and azonafide-derived compounds, showcasing his commitment to advancing medical science.
Latest Patents
Dyba's latest patents include K-Ras modulators, which are designed to inhibit K-Ras proteins, providing compositions for treating cancer. Additionally, he has developed azonafide-derived tumor and cancer-targeting compounds, which involve a method of using these compounds to deliver cytotoxic agents to cells effectively.
Career Highlights
Throughout his career, Marcin Dyba has worked with esteemed institutions such as the University of California and Leidos Biomedical Research, Inc. His work has significantly impacted the field of cancer research, contributing to the development of targeted therapies.
Collaborations
Dyba has collaborated with prominent figures in the field, including Frank McCormick and Adam Renslo. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Marcin Dyba's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patents and collaborations reflect a dedication to improving treatment options for patients.